Minesse (Ethinylestradiol, Gestodene | Lactose Anhydrous)

Minesse, a combined oral contraceptive, acts on the hypothalamic‑pituitary‑ovarian axis to prevent ovulation.

• Prevention of pregnancy: reliably inhibits ovulation and creates cervical mucus that blocks sperm entry.
• Menstrual cycle regulation: helps establish a predictable bleeding pattern and reduces irregular spotting.
• Dysmenorrhea management: can lessen the severity of painful menstrual cramps.

• Minesse combines ethinylestradiol, an estrogen, with gestodene, a progestogen, to suppress the hypothalamic‑pituitary‑ovarian axis. The regimen blocks the mid‑cycle surge of luteinising hormone (LH) and follicle‑stimulating hormone (FSH), preventing follicular rupture and ovulation. It also thickens cervical mucus, reducing sperm penetration, and induces endometrial changes that make implantation unlikely.

Minesse may cause a range of adverse reactions. Most are mild and transient, but serious events can occur.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Breast tenderness: temporary swelling or discomfort.
• Headache: occasional tension‑type headache.
• Breakthrough bleeding: spotting between periods.
• Mood changes: irritability or mild mood swings.
• Weight fluctuation: slight increase or decrease.

Serious or Rare Side Effects

• Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism.
• Arterial thrombosis: stroke or myocardial infarction.
• Severe hypertension: sudden, high blood pressure.
• Liver dysfunction: jaundice or abnormal liver enzymes.
• Anaphylaxis: rare severe allergic reaction.

Before prescribing Minesse, clinicians should evaluate patient history and risk factors.

• Pregnancy contraindication: do not use in women who are or may become pregnant.
• Smoking restriction: avoid in women over 35 who smoke.
• Thromboembolic history: contraindicated in patients with prior clotting disorders.
• Liver disease: use with caution in hepatic impairment.
• Hypertension: monitor blood pressure regularly.
• Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Minesse can interact with several medicines, altering its effectiveness or safety.

Major Interactions (Avoid)

• Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): markedly reduce contraceptive efficacy.
• Rifampicin and other strong CYP3A4 inducers: may lead to contraceptive failure.
• St. John’s wort: herbal inducer that can diminish hormone levels.

Moderate Interactions (Monitor Closely)

• Antifungal agents (e.g., ketoconazole, itraconazole): may increase hormone concentrations.
• Certain antiretrovirals (e.g., efavirenz): can lower effectiveness.
• Selective serotonin reuptake inhibitors (SSRIs): may slightly increase risk of bleeding.